Green Cross Medical Science Corporation (KOSDAQ: 142280)
4,025.00
+105.00 (2.68%)
Sep 11, 2024, 10:05 AM KST
Green Cross Medical Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,176 | 1,797 | -3,581 | -21,202 | 6,717 | -16,205 | Upgrade
|
Depreciation & Amortization | 3,938 | 3,854 | 4,107 | 3,831 | 3,162 | 2,972 | Upgrade
|
Loss (Gain) From Sale of Assets | -2.35 | 9.99 | -3.55 | -3.77 | -862.12 | -1.87 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | 5,101 | Upgrade
|
Loss (Gain) From Sale of Investments | 396.55 | 396.55 | -650.69 | -49.98 | -34.56 | -23.52 | Upgrade
|
Provision & Write-off of Bad Debts | 386.08 | 265.8 | 608.87 | 7,210 | -12.12 | -5.25 | Upgrade
|
Other Operating Activities | -1,644 | 559.11 | -263.1 | 7,252 | 2,997 | 99.41 | Upgrade
|
Change in Accounts Receivable | -1,563 | -1,432 | 502.23 | 908.72 | -5,763 | -1,356 | Upgrade
|
Change in Inventory | -903.18 | 626.73 | 15,324 | -9,254 | -19,245 | 993.23 | Upgrade
|
Change in Accounts Payable | 1,068 | 1,058 | -2,273 | -7,545 | 6,808 | 380.79 | Upgrade
|
Change in Other Net Operating Assets | 903.15 | -2,894 | -2,891 | 658.53 | -2,527 | 3,938 | Upgrade
|
Operating Cash Flow | 3,756 | 4,241 | 10,880 | -18,195 | -8,760 | -4,108 | Upgrade
|
Operating Cash Flow Growth | 30.40% | -61.02% | - | - | - | - | Upgrade
|
Capital Expenditures | -6,320 | -5,632 | -3,426 | -3,598 | -2,554 | -22,460 | Upgrade
|
Sale of Property, Plant & Equipment | 2.72 | 8.81 | 300.15 | 124.39 | 46.7 | 20.74 | Upgrade
|
Divestitures | - | - | - | - | 2,500 | - | Upgrade
|
Sale (Purchase) of Intangibles | -137.24 | -250 | -75.95 | - | -28.86 | 144.47 | Upgrade
|
Investment in Securities | 0 | 1,793 | -2,472 | 740.98 | 2,643 | 117.2 | Upgrade
|
Other Investing Activities | -9.36 | 256.95 | -0 | - | - | -0 | Upgrade
|
Investing Cash Flow | -6,464 | -3,823 | -5,675 | -3,279 | 2,607 | -22,178 | Upgrade
|
Short-Term Debt Issued | - | 13,800 | 29,940 | 129,900 | 5,800 | 46,600 | Upgrade
|
Long-Term Debt Issued | - | - | 30,000 | - | 800 | - | Upgrade
|
Total Debt Issued | 18,000 | 13,800 | 59,940 | 129,900 | 6,600 | 46,600 | Upgrade
|
Short-Term Debt Repaid | - | -16,216 | -57,212 | -110,187 | -3,410 | -45,918 | Upgrade
|
Long-Term Debt Repaid | - | -1,019 | -962.68 | -889.9 | -1,202 | -20,434 | Upgrade
|
Total Debt Repaid | -18,233 | -17,235 | -58,175 | -111,077 | -4,612 | -66,352 | Upgrade
|
Net Debt Issued (Repaid) | -232.84 | -3,435 | 1,765 | 18,823 | 1,988 | -19,752 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 51,578 | Upgrade
|
Other Financing Activities | -0.96 | - | -0 | -0 | - | -698.61 | Upgrade
|
Financing Cash Flow | -233.81 | -3,435 | 1,765 | 18,823 | 1,988 | 31,127 | Upgrade
|
Foreign Exchange Rate Adjustments | -9.32 | 9.59 | -62.79 | 0.71 | -21.71 | -12.32 | Upgrade
|
Net Cash Flow | -2,951 | -3,007 | 6,908 | -2,650 | -4,187 | 4,830 | Upgrade
|
Free Cash Flow | -2,564 | -1,391 | 7,454 | -21,793 | -11,314 | -26,568 | Upgrade
|
Free Cash Flow Margin | -2.66% | -1.48% | 6.59% | -21.43% | -9.98% | -32.60% | Upgrade
|
Free Cash Flow Per Share | -13.14 | -51.96 | 353.61 | -1034.47 | -537.04 | -2406.91 | Upgrade
|
Cash Interest Paid | 1,888 | 338.74 | 667.84 | 1,134 | 214.45 | 576.22 | Upgrade
|
Cash Income Tax Paid | 38.77 | 134.94 | 65.83 | 232.3 | 4.49 | -35.94 | Upgrade
|
Levered Free Cash Flow | -14,846 | -8,253 | 26,702 | -16,568 | -13,193 | -19,280 | Upgrade
|
Unlevered Free Cash Flow | -12,720 | -6,185 | 28,499 | -15,835 | -12,901 | -18,736 | Upgrade
|
Change in Net Working Capital | 10,433 | 4,951 | -29,024 | 3,465 | 16,104 | -2,493 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.